A Study to Evaluate the Dosing of AMG 827 for Subjects With Inadequately Controlled Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

315

Participants

Timeline

Start Date

October 4, 2010

Primary Completion Date

December 21, 2011

Study Completion Date

December 21, 2011

Conditions
Asthma
Interventions
DRUG

AMG 827

SC injection.

DRUG

Placebo

SC injection.

Trial Locations (49)

Unknown

Research Site, Encinitas

Research Site, Huntington Beach

Research Site, Los Angeles

Research Site, San Diego

Research Site, Stockton

Research Site, Colorado Springs

Research Site, Stockbridge

Research Site, Baltimore

Research Site, North Dartmouth

Research Site, St Louis

Research Site, Bozeman

Research Site, Bellevue

Research Site, Skillman

Research Site, Rockville Centre

Research Site, High Point

Research Site, Cincinnati

Research Site, Lake Oswego

Research Site, Medford

Research Site, Pittsburgh

Research Site, Dallas

Research Site, El Paso

Research Site, Madison

Research Site, Feldbach

Research Site, Hallein

Research Site, Vienna

Research Site, Brussels

Research Site, Leuven

Research Site, Liège

Research Site, Calgary

Research Site, Ottawa

Research Site, Toronto

Research Site, Helsinki

Research Site, Jyväskylä

Research Site, Turku

Research Site, Edelény

Research Site, Mátraháza

Research Site, Tatabánya

Research Site, Törökbálint

Research Site, Zalaegerszeg - Pozva

Research Site, Rotterdam

Research Site, Bialystok

Research Site, Chodzież

Research Site, Gdansk

Research Site, Wroclaw

Research Site, Moscow

Research Site, Saint Petersburg

Research Site, Bucheon-si

Research Site, Seoul

Research Site, Suwon

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY